Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 1097, Issue , 2007, Pages 30-39

  Grutzendler, Jaime ^a,b   Helmin, Kathryn ^a   Tsai, Julia ^a   Gan, Wen Biao ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AD; Alzheimer's disease; Amyloid plaques; Dendrite

Indexed keywords

AMYLOID; DYE; THIOFLAVINE; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; BRAIN TISSUE; CADAVER; CELL LABELING; CELL STRUCTURE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITE; DENDRITIC SPINE; DISEASE MODEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE QUALITY; LIPOPHILICITY; MICROENVIRONMENT; MOUSE; NERVE CELL NETWORK; NEUROFILAMENT; NONHUMAN; SENILE PLAQUE; TRANSGENIC MOUSE; ANIMAL; ARTICLE; ATROPHY; CELL SIZE; GENETICS; IMAGE PROCESSING; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SYNAPSE; ULTRASTRUCTURE;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ATROPHY; CELL SIZE; DENDRITES; DENDRITIC SPINES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEURONS; PRESENILIN-1; SENILE PLAQUES; SYNAPSES;

EID: 34247639567     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1379.003     Document Type: Conference Paper

References (43)

1. ALZHEIMER, A. 1907. Uber eine eigenartige Erkyankung der Hirnrinde. Algermeine Z Psychiatrie 146-148.
2. TERRY, R.D. & R. KATZMAN. 1983. Senile dementia of the Alzheimer type. Ann. Neurol. 14: 497-506.
3. TERRY, R.D. 1997. The pathology of Alzheimer's disease: numbers count. Ann. Neurol. 41: 7.
4. YANKNER, B.A. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932.
5. LAFERLA, F.M. & S. ODDO. 2005. Alzheimer's disease: abeta, tau and synaptic dysfunction. Trends Mol. Med. 11: 170-176.
6. ARMSTRONG, R.A. 2006. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol. 44: 1-11.
7. MOTT, R.T. & C.M. HULETTE. 2005. Neuropathology of Alzheimer's disease. Neuroimag. Clin. N. Am. 15: 755-765, ix.
8. BOURAS, C. et al. 1994. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex. 4: 138-150.
9. LEWIS, D.A. et al. 1987. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J. Neurosci. 7: 1799-1808.
10. WEGIEL, J. et al. 2001. Shift from fibrillar to nonfibrillar Abeta deposits in the neocortex of subjects with Alzheimer disease. J. Alzheimer's Dis. 3: 49-57.
11. MASLIAH, E., A. MILLER & R.D. TERRY. 1993. The synaptic organization of the neocortex in Alzheimer's disease. Med. Hypotheses 41: 334-40.
12. SCHEFF, S.W. & D.A. PRICE. 1993. Synapse loss in the temporal lobe in Alzheimer's disease. Ann. Neurol. 33: 190-199.
13. GOMEZ-ISLA, T. et al. 1997. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41: 17-24.
14. TERRY, R.D. et al. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30: 572-580.
15. MASLIAH, E. et al. 1993. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43: 192-197.
16. TERRY, R.D. 2000. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59: 1118-1119.
17. SELKOE, D.J. 2002. Alzheimer's disease is a synaptic failure. Science 298: 789-791.
18. KAMENETZ, F. et al. 2003. APP processing and synaptic function. Neuron. 37: 925-937.
19. WALSH, D.M. et al. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-539.
20. D'AMORE, J.D. et al. 2003. In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories. J. Neuropathol. Exp. Neurol. 62: 137-145.
21. MUCKE, L. et al. 2000. High-level neuronal expression of abeta 1-42 in wildtype human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20: 4050-4058.
22. LINDNER, M.D. et al. 2006. Soluble Abeta and cognitive function in aged F-344 rats and Tg2576 mice. Behav. Brain Res. 173: 62-75.
23. DODART, J.C., C. MATHIS & A. UNGERER. 2000. The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes. Rev. Neurosci. 11: 75-93.
24. KOISTINAHO, M. et al. 2001. Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques. Proc. Natl. Acad. Sci. USA. 98: 14675-14680.
25. SHEMER, I. et al. 2006. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Eur. J. Neurosci. 23: 2035-2047.
26. KURT, M.A. et al. 2001. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp. Neurol. 171: 59-71.
27. MASLIAH, E. et al. 1996. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16: 5795-5811.
28. SCHEIBEL, A.B. & U. TOMIYASU. 1978. Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60: 1-8.
29. PROBST, A. et al. 1983. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 268: 249-254.
30. MASLIAH, E. et al. 1991. Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6: 729-739.
31. PHINNEY, A.L. et al. 1999. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19: 8552-8559.
32. KNOWLES, R.B. et al. 1999. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 96: 5274-5279.
33. LE, R. et al. 2001. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J. Neuropathol. Exp. Neurol. 60: 753-758.
34. BACSKAI, B.J. et al. 2003. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc. Natl. Acad. Sci. USA. 100: 12462-12467.
35. TSAI, J. et al. 2004. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat. Neurosci. 7: 1181-1183.
36. DUFF, K. et al. 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710-713.
37. HSIAO, K. et al. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
38. HOLCOMB, L. et al. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4: 97-100.
39. GAN, W.B. et al. 2000. Multicolor "DiOlistic" labeling of the nervous system using lipophilic dye combinations. Neuron 27: 219-225.
40. GRUTZENDLER, J., J. TSAI & W.B. GAN. 2003. Rapid labeling of neuronal populations by ballistic delivery of fluorescent dyes. Methods 30: 79-85.
41. SPIRES, T.L. et al. 2005. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25: 7278-7287.
42. BRENDZA, R.P. et al. 2003. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. J. Comp. Neurol. 456: 375-383.
43. EIKELENBOOM, P. et al. 2002. Neuroinflammation in Alzheimer's disease and prion disease. Glia 40: 232-239.